|
A549
|
IC50 |
11.89 3
Compound: Piperine
|
Antiproliferative activity in human A549 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human A549 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
A549
|
IC50 |
11.89 3
Compound: Piperine
|
Antiproliferative activity in human A549 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human A549 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
Bel-7402
|
IC50 |
|
Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 33026807]
|
|
Bel-7402
|
IC50 |
> 10 3
Compound: Piperine
|
Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 33026807]
|
|
BTI-TN-5B1-4
|
IC50 |
|
Inhibition of human microsomal MAO-B expressed in baculovirus infected BTI-TN-5B1-4 cells assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate preincubated with substrate for 10 mins followed by enzyme addition by spectropho
Inhibition of human microsomal MAO-B expressed in baculovirus infected BTI-TN-5B1-4 cells assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate preincubated with substrate for 10 mins followed by enzyme addition by spectropho
|
[PMID: 31711793]
|
|
BTI-TN-5B1-4
|
IC50 |
|
Inhibition of human microsomal MAO-B expressed in baculovirus infected BTI-TN-5B1-4 cells assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate preincubated with substrate for 10 mins followed by enzyme addition by spectropho
Inhibition of human microsomal MAO-B expressed in baculovirus infected BTI-TN-5B1-4 cells assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate preincubated with substrate for 10 mins followed by enzyme addition by spectropho
|
[PMID: 31711793]
|
|
COLO 205
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) COLO205 cells by SRB assay
Cytotoxicity against Homo sapiens (human) COLO205 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
DLD-1
|
IC50 |
|
Anticancer activity against human DLD-1 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human DLD-1 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 33445154]
|
|
A549
|
IC50 |
11.89 3
Compound: Piperine
|
Antiproliferative activity in human A549 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human A549 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
BTI-TN-5B1-4
|
IC50 |
|
Inhibition of human microsomal MAO-B expressed in baculovirus infected BTI-TN-5B1-4 cells assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate preincubated with substrate for 10 mins followed by enzyme addition by spectropho
Inhibition of human microsomal MAO-B expressed in baculovirus infected BTI-TN-5B1-4 cells assessed as reduction in 4-hydroxyquinoline formation using kynuramine as substrate preincubated with substrate for 10 mins followed by enzyme addition by spectropho
|
[PMID: 31711793]
|
|
DU-145
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) DU145 cells by SRB assay
Cytotoxicity against Homo sapiens (human) DU145 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
COLO 205
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) COLO205 cells by SRB assay
Cytotoxicity against Homo sapiens (human) COLO205 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
HCT-116
|
IC50 |
|
Anticancer activity against human HCT-116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human HCT-116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 33445154]
|
|
DLD-1
|
IC50 |
|
Anticancer activity against human DLD-1 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human DLD-1 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 33445154]
|
|
HeLa
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) HeLa cells after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HeLa cells after 48 hr by MTT assay
|
10.1007/s00044-013-0541-4
|
|
DU-145
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) DU145 cells by SRB assay
Cytotoxicity against Homo sapiens (human) DU145 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
Bel-7402
|
IC50 |
> 10 3
Compound: Piperine
|
Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human Bel-7402 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 33026807]
|
|
HeLa
|
IC50 |
19.21 3
Compound: Piperine
|
Antiproliferative activity in human HeLa cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human HeLa cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
HCT-116
|
IC50 |
|
Anticancer activity against human HCT-116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human HCT-116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 33445154]
|
|
HEp-2
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) Hep2 cells by SRB assay
Cytotoxicity against Homo sapiens (human) Hep2 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
HeLa
|
IC50 |
19.21 3
Compound: Piperine
|
Antiproliferative activity in human HeLa cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human HeLa cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
COLO 205
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) COLO205 cells by SRB assay
Cytotoxicity against Homo sapiens (human) COLO205 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
Hepatocyte
|
IC50 |
|
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity after 20 hrs by MTT assay relative to untreated control
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity after 20 hrs by MTT assay relative to untreated control
|
[PMID: 19775895]
|
|
HeLa
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) HeLa cells after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HeLa cells after 48 hr by MTT assay
|
10.1007/s00044-013-0541-4
|
|
Caco-2
|
IC50 |
15.5 3
Compound: Piperine
|
TP_TRANSPORTER: inhibition of Digoxin transepithelial transport (basal to apical) (Digoxin: 5 uM) in Caco-2 cells
TP_TRANSPORTER: inhibition of Digoxin transepithelial transport (basal to apical) (Digoxin: 5 uM) in Caco-2 cells
|
[PMID: 12130727]
|
|
HEp-2
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) Hep2 cells by SRB assay
Cytotoxicity against Homo sapiens (human) Hep2 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
HepG2
|
IC50 |
> 10 3
Compound: Piperine
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 33026807]
|
|
HUVEC
|
IC50 |
|
Antiinflammatory activity in HUVEC assessed as inhibition of TNFalpha-induced ICAM-1 expression incubated for 2 hrs prior to TNFalpha challenge measured after 16 hrs by ELISA
Antiinflammatory activity in HUVEC assessed as inhibition of TNFalpha-induced ICAM-1 expression incubated for 2 hrs prior to TNFalpha challenge measured after 16 hrs by ELISA
|
10.1039/C2MD20216F
|
|
Hepatocyte
|
IC50 |
|
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity after 20 hrs by MTT assay relative to untreated control
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity after 20 hrs by MTT assay relative to untreated control
|
[PMID: 19775895]
|
|
Caco-2
|
IC50 |
74.1 3
Compound: Piperine
|
TP_TRANSPORTER: inhibition of Cyclosporin A transepithelial transport (basal to apical) (Cyclosporin A: 1 uM) in Caco-2 cells
TP_TRANSPORTER: inhibition of Cyclosporin A transepithelial transport (basal to apical) (Cyclosporin A: 1 uM) in Caco-2 cells
|
[PMID: 12130727]
|
|
IMR-32
|
IC50 |
10.19 3
Compound: Piperine
|
Antiproliferative activity in human IMR32 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human IMR32 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
HepG2
|
IC50 |
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 33026807]
|
|
DLD-1
|
IC50 |
|
Anticancer activity against human DLD-1 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human DLD-1 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 33445154]
|
|
IMR-32
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) IMR32 cells by SRB assay
Cytotoxicity against Homo sapiens (human) IMR32 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
DU-145
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) DU145 cells by SRB assay
Cytotoxicity against Homo sapiens (human) DU145 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
L929
|
IC50 |
|
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity by MTT assay relative to untreated control
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity by MTT assay relative to untreated control
|
[PMID: 19775895]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) MCF7 cells after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) MCF7 cells after 48 hr by MTT assay
|
10.1007/s00044-013-0541-4
|
|
HCT-116
|
IC50 |
|
Anticancer activity against human HCT-116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human HCT-116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 33445154]
|
|
MCF7
|
IC50 |
12.96 3
Compound: Piperine
|
Antiproliferative activity in human MCF7 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human MCF7 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
HUVEC
|
IC50 |
|
Antiinflammatory activity in HUVEC assessed as inhibition of TNFalpha-induced ICAM-1 expression incubated for 2 hrs prior to TNFalpha challenge measured after 16 hrs by ELISA
Antiinflammatory activity in HUVEC assessed as inhibition of TNFalpha-induced ICAM-1 expression incubated for 2 hrs prior to TNFalpha challenge measured after 16 hrs by ELISA
|
10.1039/C2MD20216F
|
|
MCF7
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) MCF7 cells by SRB assay
Cytotoxicity against Homo sapiens (human) MCF7 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
HEp-2
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) Hep2 cells by SRB assay
Cytotoxicity against Homo sapiens (human) Hep2 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
IMR-32
|
IC50 |
10.19 3
Compound: Piperine
|
Antiproliferative activity in human IMR32 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human IMR32 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
MDA-MB-231
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells assessed as growth inhibition by MTT assay
Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells assessed as growth inhibition by MTT assay
|
10.1007/s00044-012-0397-z
|
|
IMR-32
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) IMR32 cells by SRB assay
Cytotoxicity against Homo sapiens (human) IMR32 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
Oocyte
|
EC50 |
|
Activation of rat GABA alpha-1-beta-2-gamma-2 receptor expressed in xenopus oocytes assessed as potentiation of GABA-induced chloride current after 90 secs by two microplate electrode voltage clamp assay
Activation of rat GABA alpha-1-beta-2-gamma-2 receptor expressed in xenopus oocytes assessed as potentiation of GABA-induced chloride current after 90 secs by two microplate electrode voltage clamp assay
|
[PMID: 20085307]
|
|
L929
|
IC50 |
|
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity by MTT assay relative to untreated control
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity by MTT assay relative to untreated control
|
[PMID: 19775895]
|
|
PC-3
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) PC3 cells by SRB assay
Cytotoxicity against Homo sapiens (human) PC3 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
MCF7
|
IC50 |
12.96 3
Compound: Piperine
|
Antiproliferative activity in human MCF7 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human MCF7 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
SW480
|
IC50 |
|
Anticancer activity against human SW480 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human SW480 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 33445154]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) MCF7 cells after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) MCF7 cells after 48 hr by MTT assay
|
10.1007/s00044-013-0541-4
|
|
MCF7
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) MCF7 cells by SRB assay
Cytotoxicity against Homo sapiens (human) MCF7 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
HUVEC
|
IC50 |
|
Antiinflammatory activity in HUVEC assessed as inhibition of TNFalpha-induced ICAM-1 expression incubated for 2 hrs prior to TNFalpha challenge measured after 16 hrs by ELISA
Antiinflammatory activity in HUVEC assessed as inhibition of TNFalpha-induced ICAM-1 expression incubated for 2 hrs prior to TNFalpha challenge measured after 16 hrs by ELISA
|
10.1039/C2MD20216F
|
|
MDA-MB-231
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells assessed as growth inhibition by MTT assay
Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells assessed as growth inhibition by MTT assay
|
10.1007/s00044-012-0397-z
|
|
Oocyte
|
EC50 |
|
Activation of rat GABA alpha-1-beta-2-gamma-2 receptor expressed in xenopus oocytes assessed as potentiation of GABA-induced chloride current after 90 secs by two microplate electrode voltage clamp assay
Activation of rat GABA alpha-1-beta-2-gamma-2 receptor expressed in xenopus oocytes assessed as potentiation of GABA-induced chloride current after 90 secs by two microplate electrode voltage clamp assay
|
[PMID: 20085307]
|
|
PC-3
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) PC3 cells by SRB assay
Cytotoxicity against Homo sapiens (human) PC3 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
HeLa
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) HeLa cells after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) HeLa cells after 48 hr by MTT assay
|
10.1007/s00044-013-0541-4
|
|
SW480
|
IC50 |
|
Anticancer activity against human SW480 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human SW480 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 33445154]
|
|
HeLa
|
IC50 |
19.21 3
Compound: Piperine
|
Antiproliferative activity in human HeLa cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human HeLa cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
HepG2
|
IC50 |
> 10 3
Compound: Piperine
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 33026807]
|
|
HepG2 2.2.15
|
CC50 |
|
Cytotoxicity against human HepG2(2.2.15) cells
Cytotoxicity against human HepG2(2.2.15) cells
|
[PMID: 23434420]
|
|
HepG2 2.2.15
|
IC50 |
|
Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion
Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBeAg secretion
|
[PMID: 23434420]
|
|
HepG2 2.2.15
|
IC50 |
|
Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion
Antiviral activity against Hepatitis B virus-infected human HepG2(2.2.15) cells assessed as inhibition of HBsAg secretion
|
[PMID: 23434420]
|
|
Hepatocyte
|
IC50 |
|
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity after 20 hrs by MTT assay relative to untreated control
Hepatoprotective activity in ddY mouse hepatocytes assessed as inhibition of D-galactosamine/TNFalpha-induced cytotoxicity after 20 hrs by MTT assay relative to untreated control
|
[PMID: 19775895]
|
|
IMR-32
|
IC50 |
10.19 3
Compound: Piperine
|
Antiproliferative activity in human IMR32 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human IMR32 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
IMR-32
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) IMR32 cells by SRB assay
Cytotoxicity against Homo sapiens (human) IMR32 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
L929
|
IC50 |
|
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity by MTT assay relative to untreated control
Cytoprotective activity in mouse L929 cells assessed as inhibition of TNF-alpha-induced cytotoxicity by MTT assay relative to untreated control
|
[PMID: 19775895]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) MCF7 cells after 48 hr by MTT assay
Cytotoxicity against Homo sapiens (human) MCF7 cells after 48 hr by MTT assay
|
10.1007/s00044-013-0541-4
|
|
MCF7
|
IC50 |
12.96 3
Compound: Piperine
|
Antiproliferative activity in human MCF7 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
Antiproliferative activity in human MCF7 cells assessed as reduction in cell number incubated for 48 hrs by SRB assay
|
[PMID: 30108756]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) MCF7 cells by SRB assay
Cytotoxicity against Homo sapiens (human) MCF7 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
MDA-MB-231
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells assessed as growth inhibition by MTT assay
Cytotoxicity against Homo sapiens (human) MDA-MB-231 cells assessed as growth inhibition by MTT assay
|
10.1007/s00044-012-0397-z
|
|
Oocyte
|
EC50 |
|
Activation of rat GABA alpha-1-beta-2-gamma-2 receptor expressed in xenopus oocytes assessed as potentiation of GABA-induced chloride current after 90 secs by two microplate electrode voltage clamp assay
Activation of rat GABA alpha-1-beta-2-gamma-2 receptor expressed in xenopus oocytes assessed as potentiation of GABA-induced chloride current after 90 secs by two microplate electrode voltage clamp assay
|
[PMID: 20085307]
|
|
PC-3
|
IC50 |
|
Cytotoxicity against Homo sapiens (human) PC3 cells by SRB assay
Cytotoxicity against Homo sapiens (human) PC3 cells by SRB assay
|
10.1007/s00044-010-9500-5
|
|
SW480
|
IC50 |
|
Anticancer activity against human SW480 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Anticancer activity against human SW480 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 33445154]
|
|
WI-38
|
IC50 |
|
Induction of senescence in human WI-38 cells
Induction of senescence in human WI-38 cells
|
[PMID: 38436272]
|